| 326 |
Reactive oxygen species leading to growth inhibition via lipid peroxidation and decreased cell proliferation |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 327 |
Excessive reactive oxygen species production leading to mortality (1) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 328 |
Excessive reactive oxygen species production leading to mortality (2) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 329 |
Excessive reactive oxygen species production leading to mortality (3) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 330 |
Excessive reactive oxygen species production leading to mortality (4) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 322 |
Alkylation of DNA leading to decreased sperm count |
Carole Yauk |
BY-SA |
97: Alkylation, DNA
|
1757: Decrease, Sperm count
|
|
|
| 323 |
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone |
Jennifer Olker |
BY-SA |
227: Activation, PPARα
|
2 AOs
|
|
|
| 334 |
Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration |
Alexander Cole |
BY-SA |
122: Increase, Glucocorticoid receptor activation
|
360: Decrease, Population growth rate
|
|
|
| 335 |
AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment |
Nathalia Pereira Souza |
BY-SA |
177: Increase, Mitochondrial dysfunction
|
1763: Urothelial Tumor
|
|
|
| 338 |
DNA methyltransferase inhibition leading to population decline (3) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|
| 331 |
Reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 627 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 628 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 629 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 630 |
Decreased 11β-Hydroxysteroid dehydrogenase type 2 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2409: Decrease, 11β-Hydroxysteroid dehydrogenase type 2 activity
|
None
|
Under Development |
|
| 624 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 625 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 626 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 139 |
Alkylation of DNA leading to cancer 1 |
Carole Yauk |
Open for adoption |
97: Alkylation, DNA
|
885: Increase, Cancer
|
|
|
| 160 |
Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality |
Knut Erik Tollefsen |
BY-SA |
762: Activation, ionotropic GABA Receptor chloride channel
|
351: Increased Mortality
|
|
|
| 161 |
Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality |
Knut Erik Tollefsen |
BY-SA |
1018: Activation, Glutamate-gated chloride channels
|
351: Increased Mortality
|
|
|
| 32 |
Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors |
Undefined |
BY-SA |
None
|
None
|
|
|
| 4 |
Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 |
Knut Erik Tollefsen |
BY-SA |
103: Increase, Ecdysone receptor hyperactivation
|
2 AOs
|
|
|
| 19 |
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) |
Mukesh Patel |
Open for adoption |
26: Antagonism, Androgen receptor
|
337: N/A, Impairment of reproductive capacity
|
|
|
| 26 |
Calcium-mediated neuronal ROS production and energy imbalance |
Lyle Burgoon |
Open for adoption |
51: Inhibition, Ca++ ATPase
|
1392: Increase, Oxidative Stress
|
|
|